DIGIPHARM - The Future of Healthcare Revolution With Blockchain Technology
Hello friends, come back again with me and this time I will review about health platform that is Digifarm. For more details, let's look at the following reviews.
About Digipharms
The Digipharms solution aims to accelerate the restructuring of the great need for health care. systems for this value-based approach. The lack of current international clinics leads to significant inefficiencies, waste and at least the best health performance
In the health sector today, there is a lack of incentives for healthcare providers and services to focus on cooperation
Platform Digipharm
The refund platform uses automated "smart contracting" elements, enabling the application of a real-time model flexible pricing system and access to patients between healthcare providers, healthcare payers and information systems and administrative infrastructure involving organizations will eliminate the need for manual data handling and processing prices.
Platform rebates significantly reduce operating costs associated with implementing value-based pricing systems and potentially changing drug prices and delivering health services as we know them today.
The terms of the personal contracts received will be encrypted on the Reimburse platform through an accessible and automated user interface.
implementation when agreement conditions are met. The replacement will also make the implementation of various conditions in the same deal price as the use of smart technology contracts, thereby providing more active and personal pricing solutions while passing through the single connection infrastructure barrier.
The dynamic nature of health care and replacement systems allows manufacturers to manage and monitor their budgets more efficiently than the possibility of current comprehensive contract prices will not lead to the use or further costs incurred if a detailed deal is implemented by the current system.
For example, it is possible to receive a 50% return of treatment costs after 6 months of patient survival and 75% of treatment costs ranging from 6 to 9 months and then 100% post-administration care costs, based on frequency of adverse events, disease indicators and hospitalization which is slower for treatment, with additional additional management burden
Digipharm Vision
Digipharm's vision is to be "the provision of entrepreneurship-based citizen-based services, the generation of innovation evidence and empathy for patients in health

Industry 'using revolutionary blockchain technology. Digipharm aims to utilize new blockchain technology to overcome obstacles
Innovative patient and price access, reducing the cost of all stakeholders, and reducing the lack of infrastructure to drive value enhancement, encouraging innovation and transition expeditions to private healthcare.
No platform is available that can provide scalable functionality and pricing solutions to facilitate financing solutions between producer and payer.
As pharmaceutical innovation develops further, it is expected hundreds of new drugs will make it approved for the next 5 years. There are more than 7,000 drugs in clinical development worldwide, more than ever (PhRMA 2017); with more than 450 new clinical trials starting in 2017 alone (Reuters 2017). Experts estimate that of the 7000 developing drugs there are about 70% who tend to be first in the class.

In some areas of the disease, some new drugs combine to support the best results for patients in active studies (eg, on cancer). With a large number of innovations willing to provide unparalleled benefits to patients, healthcare and producers must work together to adopt appropriate new pricing solutions.
cancer drugs have been studied extensively in recent years and are driving growth in 2009, these pharmaceutical drug pipelines create considerable challenges because they often carry heavy price tags that explain the benefits they receive. The cost of patented cancer
Drugs in the United States alone have increased 5-10 times from the turn of the century, with an average cost of treatment of $ 100,000 a year in patients who are usually responsible for 20-30% of co-payments (Kantarijan et al 2014). High prices for innovative treatments that may or may not work can lead to rejection of patient treatment or choose a less than optimal maintenance plan due to financial difficulties they may face (Zafar et al 2013).
In the United States, UnitedHealth's leading agents, Aetna and Anthem are close to achieving their current target of 50% of total annual health care through value-added treatments.
For more details on this "Digipharm" project, let's take a look at the video below;
Pre - Sales: 15,000,000 DPH
Basic Price: 1.00 USD
Pre Sold Length: 4 Weeks
Pre-Sales Discount: 35%
Main Sales: 50.000.000 DPH
Week 1: 25% Frozen 25 million tokens
Week 2: 15% Frozen 15 million tokens
Week 3: 10% Frozen 10 million tokens
Week 4: 1.00 USD

Digipharm (DPH) tokens will be used to pay license fees / access on the Digipharm platform. Access fees will always be determined and set in USD value and the number of tokens required will depend on the type of access (producer, patient, payer or provider) combined with the necessary interaction form. The quantity of tokens required for such interactions may change, relative to the market value of the DPH.
Conclusion
That is my review of the Digipharm Platform as I explained above, my conclusion about Digipharm is a very good platform and I highly recommend it for you all. For that you should not hesitate if during this time you are looking for a health platform based on blockchain technology you have found what you have been looking for Digipharm of course. Some of the advantages and comfort that is sure to make you more sure again that this platform is very good.
Team

Advisor

To know More About This Project, Please Visit The Following Links Below:
Website: https://www.digipharm.ch
Whitepaper: https://digipharm.ch/docs/DigipharmWP.pdf
Facebook: https://www.facebook.com/digipharmteam/
Twitter: https://twitter.com/DigipharmTeam
Medium: https://medium.com/@digipharm
Telegram: https://t.me/joinchat/ExOHxk-TuOplQDbBWXaLaQ
Bitcointal Profile: https://bitcointalk.org/index.php?action=profile;u=1409779
Komentar
Posting Komentar